Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 27 (11), 1834-1846
- https://doi.org/10.1016/j.clinthera.2005.11.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 yearsCurrent Medical Research and Opinion, 2005
- Surrogate Markers for Long-Term Renal Allograft SurvivalAmerican Journal of Transplantation, 2004
- Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns StudyKidney International, 2003
- The evolving role of sirolimus in renal transplantation.QJM: An International Journal of Medicine, 2003
- Sirolimus (Rapamune) in renal transplantationCurrent Opinion in Nephrology and Hypertension, 2002
- Use of sirolimus in kidney transplantationProgress in Transplantation, 2001
- Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantationNephrology Dialysis Transplantation, 2001
- Combination treatment with sirolimus and ciclosporin in clinical renal transplantation: A comprehensive reviewDrugs of Today, 2001
- Cost-Effectiveness Studies of Renal TransplantationInternational Journal of Technology Assessment in Health Care, 1995
- Action and Toxicity of CyclosporineAnnual Review of Medicine, 1986